Anke Engelen
YOU?
Author Swipe
View article: Lanreotide in the prevention and management of high-output ileostomy after colorectal cancer surgery
Lanreotide in the prevention and management of high-output ileostomy after colorectal cancer surgery Open
Objective: Patients with stage III and high-risk stage II colorectal cancer (CRC) are advised to initiate adjuvant treatment as soon as feasible and certainly before 8 to 12 weeks after resection of the tumor. A protective ileostomy is oft…